IPOPLUS

₹25,955

▼ -145 -0.56%

17 Jun 2026

NSE Listed · Pharmaceuticals

Abbott India Limited (ABBOTINDIA)

Volume: 641Avg Vol 1W: 2,352Avg Vol 1M: 3,74952W Range:₹25,150₹37,000
NSE BSE
₹25,955▼ 0.56%
Key Ratios
Updated just now
Market Cap₹465 Cr
Current Price₹25,955
Previous Close₹26,100
High / Low (52w)₹37,000 / ₹25,150
Volume641
Avg Vol (1W)2,352
Avg Vol (1M)3,749
Stock P/E46.17
Book Value₹2,246.68
Dividend Yield4.18%
ROE37.86%
ROA33.03%
Revenue (TTM)—
Revenue Growth—
Profit Margin13.6%
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹185.85
P/B12.37
Debt / Equity0.02
50 DMA₹26,964.19
200 DMA₹26,633.48
Day change-0.56%
Price Chart
₹25,955▼ 14.34% · 1Y
₹32094₹2519855K
2025-10-21
2026-06-16

20-day avg volume: 4K shares

Pros
  • Healthy return on equity of 37.9%.
  • Pays a dividend yield of 4.2%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,710 Cr₹1,724 Cr₹1,757 Cr₹1,738 Cr₹1,605 Cr₹1,614 Cr₹1,633 Cr₹1,558 Cr₹1,439 Cr₹1,437 Cr₹1,494 Cr₹1,479 Cr₹1,343 Cr₹1,322 Cr₹1,379 Cr₹1,304 Cr₹1,255 Cr₹1,224 Cr₹1,222 Cr₹1,218 Cr₹1,096 Cr₹1,095 Cr₹1,055 Cr₹1,064 Cr₹961 Cr
EBITDA₹537 Cr₹514 Cr₹553 Cr₹499 Cr₹487 Cr₹490 Cr₹482 Cr₹440 Cr₹392 Cr₹425 Cr₹419 Cr₹394 Cr₹312 Cr₹339 Cr₹359 Cr₹279 Cr₹297 Cr₹271 Cr₹262 Cr₹269 Cr₹207 Cr₹242 Cr₹248 Cr₹247 Cr₹152 Cr
Net Profit₹395 Cr₹376 Cr₹415 Cr₹366 Cr₹367 Cr₹361 Cr₹359 Cr₹328 Cr₹287 Cr₹311 Cr₹313 Cr₹290 Cr₹231 Cr₹247 Cr₹266 Cr₹206 Cr₹211 Cr₹199 Cr₹192 Cr₹196 Cr₹152 Cr₹177 Cr₹181 Cr₹180 Cr₹111 Cr
EPS185.85176.92195.42172.17172.72169.78168.76154.36135.09146.34147.24136.58108.9116.16124.9596.7799.4993.7490.5192.1271.7583.3685.0584.8752.22
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹6,685 Cr₹6,097 Cr₹5,503 Cr₹4,996 Cr₹4,391 Cr₹4,208 Cr
EBITDA₹1,898 Cr₹1,630 Cr₹1,290 Cr₹1,099 Cr₹944 Cr₹811 Cr
Net Profit₹1,414 Cr₹1,201 Cr₹949 Cr₹799 Cr₹691 Cr₹593 Cr
EPS665.62565.28446.8375.87325.04279.04
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹5,917 Cr₹5,193 Cr₹4,556 Cr₹4,224 Cr₹3,840 Cr₹3,547 Cr
Total Liabilities₹1,684 Cr₹1,495 Cr₹1,367 Cr₹1,404 Cr₹1,238 Cr₹1,115 Cr
Equity₹4,233 Cr₹3,699 Cr₹3,189 Cr₹2,820 Cr₹2,602 Cr₹2,432 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹1,459 Cr₹1,617 Cr₹1,234 Cr₹1,237 Cr₹962 Cr₹855 Cr
Investing₹182 Cr₹-416 Cr₹-148 Cr₹-396 Cr₹-72 Cr₹-401 Cr
Financing₹-925 Cr₹-745 Cr₹-639 Cr₹-637 Cr₹-582 Cr₹-217 Cr
Free Cash Flow₹1,459 Cr₹1,617 Cr₹1,234 Cr₹1,237 Cr₹962 Cr₹855 Cr
Shareholding
Promoter 74.99% Institutions 9.2% Public 15.81%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search